“IBC “Generium” is a scientific research company with a mission to develop safe and effective biotechnology-based medical products and cell-based technologies to the stage of industrial application. Our highly qualified scientific staff and the state-of-the-art facilities allow us to design and develop virtually any recombinant protein, monoclonal antibody or cell-based product, suitable for industrial manufacturing, preclinical and clinical studies.

We draw our ideas for novel and generic medical products from the products developed by our own company as well as those of others in biotech and pharmaceutical industry, suitable for licensing in the Russian Federation. The main condition for licensing of the medicinal product or cell-based technology is the ability to organize the full cycle manufacturing of this product and transfer all the necessary technological know-how to the Russian Federation.